XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders' Equity and Warrants
6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity and Warrants
Note 10. Stockholders' Equity and Warrants
Common Shares Outstanding and Common Stock Equivalents
The following table shows the number of our common shares that could be issued for each component of our capital structure.
June 30,
2025
December 31,
2024
Outstanding common shares, excluding shares held by the Reciprocal Segment103,907101,458
Outstanding common shares held by the Reciprocal Segment(1)18,31218,312
Outstanding common shares, total122,219119,770
Common shares reserved for future issuance:
Private warrants1,7961,796
Stock options3,0203,181
Restricted and performance stock units and awards (Note 11)14,30114,119
2020 Equity Plan pool reserved for future issuance (Note 11)10,2957,698
Convertible senior unsecured notes, due 2026(2)8226,950
Convertible senior secured notes, due 202813,33213,332
Convertible senior unsecured notes, due 20308,527
Total shares of common stock outstanding and reserved for future issuance174,312166,846
______________________________________
(1)Represents shares of common stock held by the Reciprocal as of Homeowners of America (“HOA”) as of December 31, 2024, and held by the Reciprocal as of June 30, 2025 (following the distribution of such shares to the Reciprocal in connection with the sale of HOA to the Reciprocal in the first quarter of 2025).
(2)In connection with the September 16, 2021, issuance of the 2026 Notes, we used a portion of the proceeds to pay for the capped call transactions, which are expected to generally reduce the potential dilution to our common stock. The capped call transactions impact the number of shares that may be issued by effectively increasing our conversion price from $25 per share to approximately $37.74, which would result in approximately 0.5 million potentially dilutive shares instead of the shares reported in this table as of June 30, 2025.

Warrants
There was no activity related to private warrants during the six months ended June 30, 2025 and 2024. As of June 30, 2025, and December 31, 2024, there were 1.8 million private warrants outstanding for common shares. The exercise price of these private warrants is $11.50, and they expire on December 23, 2025. The private warrants are liability classified financial instruments measured at fair value, with periodic changes in fair value recognized through earnings and are included in “change in fair value of private warrant liability” in the unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). See Note 6 for more information.